MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/08971900261486909

Медицинская библиотека · Journal of pharmacy practice · 2026

Refractory Vasoplegia Following Nimodipine Administration in Aneurysmal Subarachnoid Hemorrhage: A Case Series.

Lajeunesse Brooke, Stout Catherine, McGovern Stephanie, Martindale Patrick Scott, Shim Dayoung, Barthol Colleen, Martinez Paola

СтатьяПеревод в очереди

Аннотация

Introduction

Following aneurysmal subarachnoid hemorrhage (aSAH), approximately 30% of patients experience delayed cerebral ischemia (DCI). Nimodipine, a cerebroselective dihydropyridine calcium channel blocker, reduces this risk of DCI with <5% of patients experiencing hypotension or bradycardia. We review four patients admitted to our Neurosciences Intensive Care Unit following aSAH who developed nimodipine-induced refractory vasoplegia. We discuss these four cases and detail the interventions used to counter their bradycardia and hypotension.

Methods

We performed a retrospective chart review to examine vasopressor use and interventions required to combat hypotension and bradycardia as well as patient demographics and comorbidities to identify risk factors for nimodipine-induced vasoplegia. Similar case studies were reviewed. We performed a literature search to suggest treatment options for nimodipine toxicity and assess the risk of Nimodipine dose adjustments in possibly increasing DCI occurrence.

Results

Patients required 6.5 medications on average to treat vasoplegia. Transvenous pacing and intubation were required for two patients. On average, vasoplegia lasted 18 hours and patients were slowly weaned off vasopressors. Risk factors for vasoplegia include liver and kidney disease. Nimodipine formulation may contribute to vasoplegia. Dose adjustments of nimodipine may increase risk of DCI.

Conclusion

In our literature review, nimodipine is generally well-tolerated and reduces DCI. Mild to moderate hypotension requiring vasopressor support should be expected. In cases of refractory vasoplegia resulting in cardiovascular collapse, we recommend cessation of nimodipine and treating as calcium channel blocker toxicity along with the use of nitric oxide scavengers given nimodipine's mechanism of action and the mechanism of vasoplegia.

Для цитирования: Lajeunesse Brooke, Stout Catherine, McGovern Stephanie, Martindale Patrick Scott, Shim Dayoung, Barthol Colleen, Martinez Paola. Refractory Vasoplegia Following Nimodipine Administration in Aneurysmal Subarachnoid Hemorrhage: A Case Series.. Journal of pharmacy practice. 2026. DOI: 10.1177/08971900261486909.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.